United States

Aegerion Pharmaceuticals Inc (AEGR)

Track

Track

Ticker: AEGR
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Broadfin Healthcare Master Fund Ltd Large shareholder
Transaction date
Purchase
Price
195.39
Quantity 12,887 +18.8%
Value US$4,047,288
Broadfin Healthcare Master Fund Ltd Large shareholder
Transaction date
Purchase
Price
32.58
Quantity 75,813 +36.0%
Value US$2,336,246
Broadfin Healthcare Master Fund Ltd Large shareholder
Transaction date
Purchase
Price
475.32
Quantity 66,947 +39.2%
Value US$1,559,524
Broadfin Healthcare Master Fund Ltd Large shareholder
Transaction date
Purchase
Price
1.60
Quantity 100,000 +2.5%
Value US$159,500
Broadfin Healthcare Master Fund Ltd Large shareholder
Transaction date
Purchase
Price
10.96
Quantity 35,000 +0.9%
Value US$383,600
Broadfin Healthcare Master Fund Ltd Large shareholder
Transaction date
Purchase
Price
10.99
Quantity 5,100 +0.1%
Value US$56,049
Fitzpatrick Mark J. Chief Financial Officer Officer
Transaction date
Purchase
Price
30.64
Quantity 1,150 +13.8%
Value US$35,236
Beer Marc D Chief Executive Officer Executive Director
Transaction date
Purchase
Price
34.37
Quantity 2,300 +3.0%
Value US$79,051
Beer Marc D Chief Executive Officer Executive Director
Transaction date
Purchase
Price
33.44
Quantity 7,700 +11.1%
Value US$257,488
Beer Marc D Chief Executive Officer Executive Director
Transaction date
Purchase
Price
30.12
Quantity 10,000 +16.8%
Value US$301,200
Beer Marc D Chief Executive Officer Executive Director
Transaction date
Purchase
Price
31.59
Quantity 10,000 +20.2%
Value US$315,900
Beer Marc D Chief Executive Officer Executive Director
Transaction date
Purchase
Price
30.53
Quantity 10,000 +30.3%
Value US$305,300
VANLENT ANNE Non-Executive Director
Transaction date
Purchase
Price
35.29
Quantity 52 +1.3%
Value US$1,835
VANLENT ANNE Non-Executive Director
Transaction date
Purchase
Price
34.33
Quantity 1,948 +97.4%
Value US$66,875
VANLENT ANNE Non-Executive Director
Transaction date
Purchase
Price
33.20
Quantity 2,000 +inf%
Value US$66,400
Beer Marc D Chief Executive Officer Executive Director
Transaction date
Purchase
Price
35.31
Quantity 30,000 +1000.0%
Value US$1,059,300
Fraser Craig Pres., US/Int. Comm. & Manuf. Officer
Transaction date
Planned sale
Price
43.90
Quantity 1,171 -100.0%
Value US$51,407
Fraser Craig Pres., US/Int. Comm. & Manuf. Officer
Transaction date
Planned sale
Price
43.18
Quantity 1,079 -48.0%
Value US$46,591
Fraser Craig Pres., US/Int. Comm. & Manuf. Officer
Transaction date
Planned sale
Price
47.20
Quantity 100 -100.0%
Value US$4,720
Fraser Craig Pres., US/Int. Comm. & Manuf. Officer
Transaction date
Planned sale
Price
46.51
Quantity 1,001 -90.9%
Value US$46,557
Fraser Craig Pres., US/Int. Comm. & Manuf. Officer
Transaction date
Planned sale
Price
45.84
Quantity 1,149 -51.1%
Value US$52,670
Sumeray Mark Chief Medical Officer Officer
Transaction date
Planned sale
Price
51.98
Quantity 800 -100.0%
Value US$41,584
Sumeray Mark Chief Medical Officer Officer
Transaction date
Planned sale
Price
51.31
Quantity 900 -52.9%
Value US$46,179
Sumeray Mark Chief Medical Officer Officer
Transaction date
Planned sale
Price
49.69
Quantity 300 -15.0%
Value US$14,907
Sumeray Mark Chief Medical Officer Officer
Transaction date
Planned sale
Price
64.52
Quantity 500 -100.0%
Value US$32,260
Sumeray Mark Chief Medical Officer Officer
Transaction date
Planned sale
Price
63.14
Quantity 1,500 -75.0%
Value US$94,710
Fraser Craig Pres., US/Int. Comm. & Manuf. Officer
Transaction date
Planned sale
Price
67.00
Quantity 2,250 -100.0%
Value US$150,750
Fitzpatrick Mark J. Chief Financial Officer Officer
Transaction date
Planned sale
Price
64.69
Quantity 486 -7.7%
Value US$31,439
Fitzpatrick Mark J. Chief Financial Officer Officer
Transaction date
Planned sale
Price
63.72
Quantity 900 -12.4%
Value US$57,348
Fitzpatrick Mark J. Chief Financial Officer Officer
Transaction date
Planned sale
Price
62.94
Quantity 2,814 -28.0%
Value US$177,113
Fitzpatrick Mark J. Chief Financial Officer Officer
Transaction date
Planned sale
Price
61.71
Quantity 3,300 -24.7%
Value US$203,643
Sumeray Mark Chief Medical Officer Officer
Transaction date
Planned sale
Price
59.51
Quantity 100 -100.0%
Value US$5,951
Sumeray Mark Chief Medical Officer Officer
Transaction date
Planned sale
Price
58.59
Quantity 1,900 -95.0%
Value US$111,318
Sumeray Mark Chief Medical Officer Officer
Transaction date
Planned sale
Price
71.41
Quantity 600 -100.0%
Value US$42,847
Sumeray Mark Chief Medical Officer Officer
Transaction date
Planned sale
Price
70.22
Quantity 400 -40.0%
Value US$28,087
Fraser Craig Pres., US/Int. Comm. & Manuf. Officer
Transaction date
Planned sale
Price
71.42
Quantity 1,350 -100.0%
Value US$96,414
Fraser Craig Pres., US/Int. Comm. & Manuf. Officer
Transaction date
Planned sale
Price
70.65
Quantity 900 -40.0%
Value US$63,584
Sumeray Mark Chief Medical Officer Officer
Transaction date
Planned sale
Price
67.38
Quantity 200 -100.0%
Value US$13,476
Sumeray Mark Chief Medical Officer Officer
Transaction date
Planned sale
Price
66.23
Quantity 1,800 -90.0%
Value US$119,211
Fraser Craig Pres., US/Int. Comm. & Manuf. Officer
Transaction date
Planned sale
Price
71.10
Quantity 700 -100.0%
Value US$49,769
Fraser Craig Pres., US/Int. Comm. & Manuf. Officer
Transaction date
Planned sale
Price
70.10
Quantity 1,550 -68.9%
Value US$108,654
Sumeray Mark Chief Medical Officer Officer
Transaction date
Planned sale
Price
71.20
Quantity 600 -100.0%
Value US$42,718
Sumeray Mark Chief Medical Officer Officer
Transaction date
Planned sale
Price
70.23
Quantity 2,400 -80.0%
Value US$168,549
Sumeray Mark Chief Medical Officer Officer
Transaction date
Planned sale
Price
77.63
Quantity 500 -100.0%
Value US$38,817
Sumeray Mark Chief Medical Officer Officer
Transaction date
Planned sale
Price
75.89
Quantity 1,011 -66.9%
Value US$76,726
Sumeray Mark Chief Medical Officer Officer
Transaction date
Planned sale
Price
74.93
Quantity 489 -24.4%
Value US$36,639
Fitzpatrick Mark J. Chief Financial Officer Officer
Transaction date
Planned sale
Price
80.03
Quantity 1,800 -37.5%
Value US$144,057
Fitzpatrick Mark J. Chief Financial Officer Officer
Transaction date
Planned sale
Price
79.34
Quantity 4,478 -48.3%
Value US$355,300
Fitzpatrick Mark J. Chief Financial Officer Officer
Transaction date
Planned sale
Price
78.38
Quantity 622 -6.3%
Value US$48,755
Fitzpatrick Mark J. Chief Financial Officer Officer
Transaction date
Planned sale
Price
76.14
Quantity 200 -2.0%
Value US$15,228
Fitzpatrick Mark J. Chief Financial Officer Officer
Transaction date
Planned sale
Price
74.43
Quantity 200 -1.9%
Value US$14,886
Fitzpatrick Mark J. Chief Financial Officer Officer
Transaction date
Planned sale
Price
73.01
Quantity 200 -1.9%
Value US$14,602
Sumeray Mark Chief Medical Officer Officer
Transaction date
Planned sale
Price
84.34
Quantity 100 -100.0%
Value US$8,434
Sumeray Mark Chief Medical Officer Officer
Transaction date
Planned sale
Price
83.59
Quantity 2,000 -95.2%
Value US$167,180
Sumeray Mark Chief Medical Officer Officer
Transaction date
Planned sale
Price
82.76
Quantity 1,400 -40.0%
Value US$115,867
Fraser Craig Pres., US/Int. Comm. & Manuf. Officer
Transaction date
Planned sale
Price
83.99
Quantity 400 -100.0%
Value US$33,597
Fraser Craig Pres., US/Int. Comm. & Manuf. Officer
Transaction date
Planned sale
Price
83.22
Quantity 1,550 -79.5%
Value US$128,994
Fraser Craig Pres., US/Int. Comm. & Manuf. Officer
Transaction date
Planned sale
Price
82.28
Quantity 300 -13.3%
Value US$24,684
Carter Martha J. Chief Regulatory Officer & SVP Officer
Transaction date
Planned sale
Price
82.81
Quantity 5,000 -76.9%
Value US$414,050
Beer Marc D Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
99.18
Quantity 1,200 -0.6%
Value US$119,016
Beer Marc D Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
95.90
Quantity 300 -0.2%
Value US$28,770
Beer Marc D Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
94.25
Quantity 200 -0.1%
Value US$18,850
Beer Marc D Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
93.00
Quantity 400 -0.2%
Value US$37,200
Beer Marc D Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
92.03
Quantity 700 -0.4%
Value US$64,421
Beer Marc D Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
91.21
Quantity 2,500 -1.2%
Value US$228,031
Beer Marc D Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
89.85
Quantity 2,700 -1.3%
Value US$242,592
Beer Marc D Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
89.01
Quantity 3,800 -1.8%
Value US$338,243
Beer Marc D Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
87.83
Quantity 6,019 -2.8%
Value US$528,619
Beer Marc D Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
87.08
Quantity 10,000 -4.5%
Value US$870,752
Beer Marc D Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
85.94
Quantity 2,314 -1.0%
Value US$198,860
Beer Marc D Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
85.00
Quantity 7,067 -3.0%
Value US$600,689
Beer Marc D Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
84.15
Quantity 2,800 -1.2%
Value US$235,621
SMITH SANDFORD D Non-Executive Director
Transaction date
Planned sale
Price
95.00
Quantity 2,502 -100.0%
Value US$237,690
Sumeray Mark Chief Medical Officer Officer
Transaction date
Planned sale
Price
80.71
Quantity 1,000 -100.0%
Value US$80,709
Sumeray Mark Chief Medical Officer Officer
Transaction date
Planned sale
Price
79.95
Quantity 1,000 -50.0%
Value US$79,950
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2016-09-14 2016-09-13 B Purchase Broadfin Healthcare Master Fund Ltd Large shareholder
12,887 +18.8%
195.39
US$4,047,288 		12,887 +18.8% 195.39 US$4,047,288
2016-09-12 2016-09-12 B Purchase Broadfin Healthcare Master Fund Ltd Large shareholder
75,813 +36.0%
32.58
US$2,336,246 		75,813 +36.0% 32.58 US$2,336,246
2016-09-12 2016-09-12 B Purchase Broadfin Healthcare Master Fund Ltd Large shareholder
66,947 +39.2%
475.32
US$1,559,524 		66,947 +39.2% 475.32 US$1,559,524
2016-09-12 2016-09-09 B Purchase Broadfin Healthcare Master Fund Ltd Large shareholder
100,000 +2.5%
1.60
US$159,500 		100,000 +2.5% 1.60 US$159,500
2015-11-13 2015-11-11 B Purchase Broadfin Healthcare Master Fund Ltd Large shareholder
35,000 +0.9%
10.96
US$383,600 		35,000 +0.9% 10.96 US$383,600
2015-11-13 2015-11-11 B Purchase Broadfin Healthcare Master Fund Ltd Large shareholder
5,100 +0.1%
10.99
US$56,049 		5,100 +0.1% 10.99 US$56,049
2014-08-20 2014-08-19 B Purchase Fitzpatrick Mark J.

Chief Financial Officer

Officer
1,150 +13.8%
30.64
US$35,236 		1,150 +13.8% 30.64 US$35,236
2014-07-31 2014-07-31 B Purchase Beer Marc D

Chief Executive Officer

Executive Director
2,300 +3.0%
34.37
US$79,051 		2,300 +3.0% 34.37 US$79,051
2014-07-31 2014-07-31 B Purchase Beer Marc D

Chief Executive Officer

Executive Director
7,700 +11.1%
33.44
US$257,488 		7,700 +11.1% 33.44 US$257,488
2014-06-04 2014-06-03 B Purchase Beer Marc D

Chief Executive Officer

Executive Director
10,000 +16.8%
30.12
US$301,200 		10,000 +16.8% 30.12 US$301,200
2014-05-27 2014-05-27 B Purchase Beer Marc D

Chief Executive Officer

Executive Director
10,000 +20.2%
31.59
US$315,900 		10,000 +20.2% 31.59 US$315,900
2014-05-21 2014-05-20 B Purchase Beer Marc D

Chief Executive Officer

Executive Director
10,000 +30.3%
30.53
US$305,300 		10,000 +30.3% 30.53 US$305,300
2014-05-09 2014-05-08 B Purchase VANLENT ANNE Non-Executive Director
52 +1.3%
35.29
US$1,835 		52 +1.3% 35.29 US$1,835
2014-05-09 2014-05-08 B Purchase VANLENT ANNE Non-Executive Director
1,948 +97.4%
34.33
US$66,875 		1,948 +97.4% 34.33 US$66,875
2014-05-09 2014-05-08 B Purchase VANLENT ANNE Non-Executive Director
2,000 +inf%
33.20
US$66,400 		2,000 +inf% 33.20 US$66,400
2014-05-08 2014-05-08 B Purchase Beer Marc D

Chief Executive Officer

Executive Director
30,000 +1000.0%
35.31
US$1,059,300 		30,000 +1000.0% 35.31 US$1,059,300
2014-05-01 2014-04-30 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
1,171 -100.0%
43.90
US$51,407 		1,171 -100.0% 43.90 US$51,407
2014-05-01 2014-04-30 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
1,079 -48.0%
43.18
US$46,591 		1,079 -48.0% 43.18 US$46,591
2014-04-02 2014-03-31 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
100 -100.0%
47.20
US$4,720 		100 -100.0% 47.20 US$4,720
2014-04-02 2014-03-31 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
1,001 -90.9%
46.51
US$46,557 		1,001 -90.9% 46.51 US$46,557
2014-04-02 2014-03-31 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
1,149 -51.1%
45.84
US$52,670 		1,149 -51.1% 45.84 US$52,670
2014-03-18 2014-03-14 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
800 -100.0%
51.98
US$41,584 		800 -100.0% 51.98 US$41,584
2014-03-18 2014-03-14 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
900 -52.9%
51.31
US$46,179 		900 -52.9% 51.31 US$46,179
2014-03-18 2014-03-14 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
300 -15.0%
49.69
US$14,907 		300 -15.0% 49.69 US$14,907
2014-02-18 2014-02-14 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
500 -100.0%
64.52
US$32,260 		500 -100.0% 64.52 US$32,260
2014-02-18 2014-02-14 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
1,500 -75.0%
63.14
US$94,710 		1,500 -75.0% 63.14 US$94,710
2014-02-12 2014-02-11 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
2,250 -100.0%
67.00
US$150,750 		2,250 -100.0% 67.00 US$150,750
2014-02-12 2014-02-10 PlS Planned sale Fitzpatrick Mark J.

Chief Financial Officer

Officer
486 -7.7%
64.69
US$31,439 		486 -7.7% 64.69 US$31,439
2014-02-12 2014-02-10 PlS Planned sale Fitzpatrick Mark J.

Chief Financial Officer

Officer
900 -12.4%
63.72
US$57,348 		900 -12.4% 63.72 US$57,348
2014-02-12 2014-02-10 PlS Planned sale Fitzpatrick Mark J.

Chief Financial Officer

Officer
2,814 -28.0%
62.94
US$177,113 		2,814 -28.0% 62.94 US$177,113
2014-02-12 2014-02-10 PlS Planned sale Fitzpatrick Mark J.

Chief Financial Officer

Officer
3,300 -24.7%
61.71
US$203,643 		3,300 -24.7% 61.71 US$203,643
2014-01-21 2014-01-16 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
100 -100.0%
59.51
US$5,951 		100 -100.0% 59.51 US$5,951
2014-01-21 2014-01-16 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
1,900 -95.0%
58.59
US$111,318 		1,900 -95.0% 58.59 US$111,318
2014-01-06 2014-01-02 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
600 -100.0%
71.41
US$42,847 		600 -100.0% 71.41 US$42,847
2014-01-06 2014-01-02 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
400 -40.0%
70.22
US$28,087 		400 -40.0% 70.22 US$28,087
2014-01-06 2014-01-02 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
1,350 -100.0%
71.42
US$96,414 		1,350 -100.0% 71.42 US$96,414
2014-01-06 2014-01-02 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
900 -40.0%
70.65
US$63,584 		900 -40.0% 70.65 US$63,584
2013-12-17 2013-12-16 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
200 -100.0%
67.38
US$13,476 		200 -100.0% 67.38 US$13,476
2013-12-17 2013-12-16 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
1,800 -90.0%
66.23
US$119,211 		1,800 -90.0% 66.23 US$119,211
2013-12-04 2013-12-02 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
700 -100.0%
71.10
US$49,769 		700 -100.0% 71.10 US$49,769
2013-12-04 2013-12-02 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
1,550 -68.9%
70.10
US$108,654 		1,550 -68.9% 70.10 US$108,654
2013-12-04 2013-12-02 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
600 -100.0%
71.20
US$42,718 		600 -100.0% 71.20 US$42,718
2013-12-04 2013-12-02 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
2,400 -80.0%
70.23
US$168,549 		2,400 -80.0% 70.23 US$168,549
2013-11-19 2013-11-15 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
500 -100.0%
77.63
US$38,817 		500 -100.0% 77.63 US$38,817
2013-11-19 2013-11-15 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
1,011 -66.9%
75.89
US$76,726 		1,011 -66.9% 75.89 US$76,726
2013-11-19 2013-11-15 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
489 -24.4%
74.93
US$36,639 		489 -24.4% 74.93 US$36,639
2013-11-13 2013-11-11 PlS Planned sale Fitzpatrick Mark J.

Chief Financial Officer

Officer
1,800 -37.5%
80.03
US$144,057 		1,800 -37.5% 80.03 US$144,057
2013-11-13 2013-11-11 PlS Planned sale Fitzpatrick Mark J.

Chief Financial Officer

Officer
4,478 -48.3%
79.34
US$355,300 		4,478 -48.3% 79.34 US$355,300
2013-11-13 2013-11-11 PlS Planned sale Fitzpatrick Mark J.

Chief Financial Officer

Officer
622 -6.3%
78.38
US$48,755 		622 -6.3% 78.38 US$48,755
2013-11-13 2013-11-11 PlS Planned sale Fitzpatrick Mark J.

Chief Financial Officer

Officer
200 -2.0%
76.14
US$15,228 		200 -2.0% 76.14 US$15,228
2013-11-13 2013-11-11 PlS Planned sale Fitzpatrick Mark J.

Chief Financial Officer

Officer
200 -1.9%
74.43
US$14,886 		200 -1.9% 74.43 US$14,886
2013-11-13 2013-11-11 PlS Planned sale Fitzpatrick Mark J.

Chief Financial Officer

Officer
200 -1.9%
73.01
US$14,602 		200 -1.9% 73.01 US$14,602
2013-11-05 2013-11-01 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
100 -100.0%
84.34
US$8,434 		100 -100.0% 84.34 US$8,434
2013-11-05 2013-11-01 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
2,000 -95.2%
83.59
US$167,180 		2,000 -95.2% 83.59 US$167,180
2013-11-05 2013-11-01 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
1,400 -40.0%
82.76
US$115,867 		1,400 -40.0% 82.76 US$115,867
2013-11-05 2013-11-01 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
400 -100.0%
83.99
US$33,597 		400 -100.0% 83.99 US$33,597
2013-11-05 2013-11-01 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
1,550 -79.5%
83.22
US$128,994 		1,550 -79.5% 83.22 US$128,994
2013-11-05 2013-11-01 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
300 -13.3%
82.28
US$24,684 		300 -13.3% 82.28 US$24,684
2013-11-05 2013-11-01 PlS Planned sale Carter Martha J.

Chief Regulatory Officer & SVP

Officer
5,000 -76.9%
82.81
US$414,050 		5,000 -76.9% 82.81 US$414,050
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
1,200 -0.6%
99.18
US$119,016 		1,200 -0.6% 99.18 US$119,016
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
300 -0.2%
95.90
US$28,770 		300 -0.2% 95.90 US$28,770
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
200 -0.1%
94.25
US$18,850 		200 -0.1% 94.25 US$18,850
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
400 -0.2%
93.00
US$37,200 		400 -0.2% 93.00 US$37,200
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
700 -0.4%
92.03
US$64,421 		700 -0.4% 92.03 US$64,421
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
2,500 -1.2%
91.21
US$228,031 		2,500 -1.2% 91.21 US$228,031
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
2,700 -1.3%
89.85
US$242,592 		2,700 -1.3% 89.85 US$242,592
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
3,800 -1.8%
89.01
US$338,243 		3,800 -1.8% 89.01 US$338,243
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
6,019 -2.8%
87.83
US$528,619 		6,019 -2.8% 87.83 US$528,619
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
10,000 -4.5%
87.08
US$870,752 		10,000 -4.5% 87.08 US$870,752
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
2,314 -1.0%
85.94
US$198,860 		2,314 -1.0% 85.94 US$198,860
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
7,067 -3.0%
85.00
US$600,689 		7,067 -3.0% 85.00 US$600,689
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
2,800 -1.2%
84.15
US$235,621 		2,800 -1.2% 84.15 US$235,621
2013-10-31 2013-10-29 PlS Planned sale SMITH SANDFORD D Non-Executive Director
2,502 -100.0%
95.00
US$237,690 		2,502 -100.0% 95.00 US$237,690
2013-10-16 2013-10-15 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
1,000 -100.0%
80.71
US$80,709 		1,000 -100.0% 80.71 US$80,709
2013-10-16 2013-10-15 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
1,000 -50.0%
79.95
US$79,950 		1,000 -50.0% 79.95 US$79,950
Explore more

More insider trading research around Aegerion Pharmaceuticals Inc

More insider trades in United States
Insider trading in North America